Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Strategies to Improve Long Term Islet Graft Survival.

Trial Profile

Strategies to Improve Long Term Islet Graft Survival.

Phase of Trial: Phase II

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Lisofylline (Primary) ; Antithymocyte globulin; Basiliximab; Sirolimus; Tacrolimus
  • Indications Islet cell transplant rejection; Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 18 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Jan 2012 Actual patient number is 5 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top